Miami-based Medical Company Secures Patent For Its Lead Technology

Longeveron Receives U.S Patent Allowance: How it Impacts You.

This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

In a significant development that has the potential to revolutionize regenerative medicine, Miami-based biopharmaceutical company Longeveron Inc. (NASDAQ: LGVN) has received notice of a United States Patent Allowance for …